BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11729 related articles for article (PubMed ID: 1146461)

  • 1. [Malignant melanomas of Lille 1967-1972. Comparison between "histoprognosis" and actual outcome (author's transl)].
    Vandenbussche F; Lekieffre M; Meresse B; Lagache G; Bombart-Thoreux M; Bergoend H; Benoit M; Houcke M; Brouet J; Huriez C
    Acta Chir Belg; 1975 Jul; 74(4):406-21. PubMed ID: 1146461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 4. The relation of cross-sectional profile, level of invasion, ulceration and vascular invasion to tumour type and prognosis.
    Larsen TE; Grude TH
    Acta Pathol Microbiol Scand A; 1979 Mar; 87A(2):131-8. PubMed ID: 433595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 3. The relation between the tumour-associated lymphocyte infiltration and age and sex, tumour cell type, pigmentation, cellular atypia, mitotic count, depth of invasion, ulceration, tumour type and prognosis.
    Larsen TE; Grude TH
    Acta Pathol Microbiol Scand A; 1978 Nov; 86A(6):523-30. PubMed ID: 716913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of prognostic factors in malignant melanoma according to the actuarial method: report of 75 cases (author's transl)].
    Pelletier N; Claudy A; Thivolet J
    Dermatologica; 1978; 157(4):210-20. PubMed ID: 689232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant melanoma: depth of invasion and histologic typing].
    Hermanek P; Hornstein OP; Tonak J; Weidner F
    Beitr Pathol; 1976 May; 157(3):269-82. PubMed ID: 1275868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depth of invasion and tumor thickness in primary cutaneous malignant melanoma. A study of 2012 cases.
    Søndergaard K
    Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):49-55. PubMed ID: 3984735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relation between the prognosis of skin melanomas and the timing of appearance of regional metastases].
    Vagner RI; Anisimov VV
    Vopr Onkol; 1986; 32(10):21-5. PubMed ID: 3776125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiology and prognostic factors in cutaneous malignant melanoma].
    Milo Y; Tamir G; Robinpour M; Sulkes J; Rotem A; Schachter J; Hauben DJ
    Harefuah; 1995 Jun; 128(12):745-51, 824. PubMed ID: 7557679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Standards, Options and Recommendations (SOR): clinical practice guidelines for diagnosis, treatment and follow-up of cutaneous melanoma. Fédération Nationale des Centres de Lutte Contre le Cancer].
    Négrier S; Fervers B; Bailly C; Beckendorf V; Cupissol D; Doré JF; Dorval T; Garbay JR; Vilmer C
    Bull Cancer; 2000 Feb; 87(2):173-82. PubMed ID: 10705288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histopathologic classification of malignant melanoma of the skin. Retrospective study of 149 cases].
    Hauser C; Gloor F
    Schweiz Med Wochenschr; 1979 Feb; 109(5):152-7. PubMed ID: 441722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant melanoma in Turkey: a single institution's experience on 475 cases.
    Tas F; Kurul S; Camlica H; Topuz E
    Jpn J Clin Oncol; 2006 Dec; 36(12):794-9. PubMed ID: 17060409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lymphogenic metastasing of malignant melanoma (author's transl)].
    Altmeyer P; Nödl F; Merkel H
    Dtsch Med Wochenschr; 1980 Dec; 105(51):1769-72. PubMed ID: 7439070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
    Phan A; Touzet S; Dalle S; Ronger-Savlé S; Balme B; Thomas L
    Br J Dermatol; 2007 Aug; 157(2):311-8. PubMed ID: 17596173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
    Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 587.